Merck & Co., Inc. MRK
Set alert
145.29 USD -3.07 -2.07%
As of Nov 3, 11:36 AM ET
144.85 Day range 147.62
82.49 52-week range 156.45
- YTD
- +38.03%
- 1 year
- +76.13%
- Open
- 147.02
- Prev close
- 148.36
- Mkt cap
- 358.59B
- Vol
- 2.39M
- Avg vol
- 10.33M
- EPS
- 0.99
- P/E
- 146.81
- Div yield
- 2.32%
More statistics
- Low
- 144.85
- High
- 147.62
- Forward P/E
- 16.34
- Beta
- 0.12
- Short ratio
- 2.68
- Inst. own
- 82.88%
- Dividend
- 3.40
- Ex-div date
- Sep 14, 2026
- Earnings
- Feb 2, 2027
- 50-d avg
- 146.86
- 200-d avg
- 126.71
- 1y target
- 159.91
MAX chart
Events in this range
- Jan 2, 1990Dividend: 0.45
- Apr 2, 1990Dividend: 0.45
- Jul 2, 1990Dividend: 0.45
- Oct 1, 1990Dividend: 0.56
- Jan 2, 1991Dividend: 0.56
- Apr 2, 1991Dividend: 0.56
- Jul 1, 1991Dividend: 0.56
- Oct 1, 1991Dividend: 0.63
- Jan 2, 1992Dividend: 0.63
- Apr 1, 1992Dividend: 0.69
- Jul 1, 1992Dividend: 0.23
- Oct 1, 1992Dividend: 0.25
- Jan 4, 1993Dividend: 0.25
- Apr 1, 1993Dividend: 0.25
- Jul 1, 1993Dividend: 0.25
- Oct 1, 1993Dividend: 0.28
- Jan 3, 1994Dividend: 0.28
- Apr 5, 1994Dividend: 0.28
Signals (50)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| RSI: Overbought | Jan 1, 2024 | 2 years ago |
| RSI: Overbought | Oct 1, 2022 | 4 years ago |
| MACD: Buy Signal | Apr 1, 2022 | 4 years ago |
| SMA: Bullish | Jan 1, 2022 | 4 years ago |
| SMA: Bearish | Jan 1, 2021 | 5 years ago |
| MACD: Sell Signal | Jan 1, 2021 | 5 years ago |
| RSI: Overbought | Jan 1, 2019 | 7 years ago |
| MACD: Buy Signal | Jul 1, 2018 | 8 years ago |
| SMA: Bullish | Apr 1, 2018 | 8 years ago |
| MACD: Sell Signal | Jan 1, 2018 | 8 years ago |
| SMA: Bearish | Oct 1, 2017 | 9 years ago |
| SMA: Bullish | Apr 1, 2016 | 10 years ago |
| SMA: Bearish | Jul 1, 2015 | 11 years ago |
| SMA: Bullish | Oct 1, 2011 | 15 years ago |
Newest 20 of 50.
Analyst view
Consensus: buy
Buy
Price target (mean) 159.91 +10.1% upside
Now 145.29
- Target (low)
- 105.00
- Target (mean)
- 159.91
- Target (high)
- 186.00
Ratings (0m) 28 19 buy · 9 hold · 0 sell
- Strong buy5
- Buy14
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 27
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.79 | 1.71 – 1.96 | 2.04 | -12.1% | 16.37B | -0.2% | 18 |
| Next quarter | 2.17 | 2.04 – 2.30 | -1.28 | +269.5% | 16.48B | +1.2% | 8 |
| Current year | 2.76 | 2.50 – 2.99 | 8.98 | -69.3% | 67.19B | +3.4% | 25 |
| Next year | 9.08 | 8.50 – 9.77 | 2.76 | +229.6% | 69.58B | +3.6% | 23 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 26, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 12, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 5, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 29, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Sep 9, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 8, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 25, 2026 | Wolfe Research | Maintained | Outperform | Outperform |
| Aug 25, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 21, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 20, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Aug 20, 2026 | UBS | Maintained | Buy | Buy |
| Aug 20, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Aug 20, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Aug 12, 2026 | Daiwa Capital | Upgrade | Neutral | Outperform |
| Aug 11, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 13, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |